Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

Grever, M; Andritsos, L; Banerji, V; Barrientos, JC; Bhat, S; Blachly, JS; Call, T; Cross, M; Dearden, C; Demeter, J; Dietrich, S; Falini, B; Forconi, F; Gladstone, DE; Gozzetti, A; Iyengar, S; Johnston, JB; Juliusson, G; Kraut, E; Kreitman, RJ; Lauria, F; Lozanski, G; Parikh, SA; Park, J; Polliack, A; Ravandi, F; Robak, T; Rogers, KA; Saven, A; Seymour, JF; Tadmor, T; Tallman, MS; Tam, CS; Tiacci, E; Troussard, X; Zent, C; Zenz, T; Zinzani, PL; Wormann, B

Grever, M (corresponding author), Ohio State Univ, Dept Med, Div Hematol, Columbus, OH 43210 USA.; Wormann, B (corresponding author), Charite, Berlin, Germany.

LEUKEMIA, 2021; 35 (7): 1864

Abstract

Standard treatment options in classic HCL (cHCL) result in high response rates and near normal life expectancy. However, the disease itself and the re......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索